Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune…
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
June 15, 2026 16:05 ET | Source: Adaptive Biotechnologies Proceeds expected to…
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
April 15, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, April 15,…
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22,…
